RESUME Trademark

Trademark Overview

On Tuesday, May 25, 2010, a trademark application was filed for RESUME with the United States Patent and Trademark Office. The USPTO has given the RESUME trademark a serial number of 85047318. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 19, 2021. This trademark is owned by Celgene Corporation. The RESUME trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

medical and scientific research, including conducting clinical trials; conducting clinical trials on the safety and effectiveness of lenalidomide; clinical trials on the safety and effectiveness of a drug for multiple myleloma
resume

General Information

Serial Number85047318
Word MarkRESUME
Filing DateTuesday, May 25, 2010
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 19, 2021
Registration Number3940196
Registration DateTuesday, April 5, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 18, 2011

Trademark Statements

Goods and Servicesmedical and scientific research, including conducting clinical trials; conducting clinical trials on the safety and effectiveness of lenalidomide; clinical trials on the safety and effectiveness of a drug for multiple myleloma

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 19, 2021
Primary Code042
First Use Anywhere DateThursday, July 15, 2010
First Use In Commerce DateThursday, July 15, 2010

Trademark Owner History

Party NameCelgene Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901
Party NameCelgene Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSummit, NJ 07901

Trademark Events

Event DateEvent Description
Friday, November 19, 2021CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sunday, April 5, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, June 13, 2016NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, June 13, 2016REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, June 13, 2016CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, April 5, 2016TEAS SECTION 8 & 15 RECEIVED
Tuesday, April 5, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, July 29, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 5, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, January 18, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 18, 2011PUBLISHED FOR OPPOSITION
Wednesday, December 15, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 15, 2010NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Tuesday, December 14, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 14, 2010USE AMENDMENT ACCEPTED
Tuesday, December 14, 2010AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, November 9, 2010USE AMENDMENT FILED
Thursday, December 9, 2010PREVIOUS ALLOWANCE WITHDRAWN-TIMELY AAU
Tuesday, November 23, 2010ASSIGNED TO LIE
Tuesday, November 9, 2010TEAS AMENDMENT OF USE RECEIVED
Wednesday, November 10, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 9, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 9, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 9, 2010TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, July 22, 2010NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, July 22, 2010LETTER OF SUSPENSION E-MAILED
Thursday, July 22, 2010SUSPENSION LETTER WRITTEN
Thursday, July 22, 2010EXAMINER'S AMENDMENT ENTERED
Thursday, July 22, 2010NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 22, 2010EXAMINERS AMENDMENT E-MAILED
Thursday, July 22, 2010EXAMINERS AMENDMENT -WRITTEN
Tuesday, July 20, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 20, 2010NON-FINAL ACTION E-MAILED
Tuesday, July 20, 2010NON-FINAL ACTION WRITTEN
Monday, July 12, 2010ASSIGNED TO EXAMINER
Friday, May 28, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, May 28, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

resume clinical trials effectiveness conducting safety drug multiple myleloma lenalidomide including